Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2435652
Max Phase: Preclinical
Molecular Formula: C24H31BrN2O
Molecular Weight: 363.53
Molecule Type: Small molecule
Associated Items:
ID: ALA2435652
Max Phase: Preclinical
Molecular Formula: C24H31BrN2O
Molecular Weight: 363.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCn1c(-c2cc[n+](CCCCC)cc2)cc(=O)c2ccccc21.[Br-]
Standard InChI: InChI=1S/C24H31N2O.BrH/c1-3-5-9-15-25-17-13-20(14-18-25)23-19-24(27)21-11-7-8-12-22(21)26(23)16-10-6-4-2;/h7-8,11-14,17-19H,3-6,9-10,15-16H2,1-2H3;1H/q+1;/p-1
Standard InChI Key: QGWGHEQDJITSHB-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 363.53 | Molecular Weight (Monoisotopic): 363.2431 | AlogP: 5.34 | #Rotatable Bonds: 9 |
Polar Surface Area: 25.88 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 1.93 | CX LogP: 1.46 | CX LogD: 1.46 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.37 | Np Likeness Score: -0.38 |
1. Kahriman N, Yaylı B, Aktaş A, Iskefiyeli Z, Beriş FŞ, Yaylı N.. (2013) Synthesis, antibacterial and antioxidant activities of new 1-alkyl-4-(1-alkyl-4-oxo-1,4-dihydroquinolin-2-yl)pyridinium bromides., 69 [PMID:24077525] [10.1016/j.ejmech.2013.08.050] |
Source(1):